▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Clene (NASDAQ: CLNN)

$3.62

(0.6%)

$0.02

Price as of August 15, 2025, 3:59 p.m. ET

Clene Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
CLNN	-25.82%	-98.33%	-55.86%	-98%
S&P	+16.35%	+91.23%	+13.83%	+123%

Clene Company Info

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.

News & Analysis

Featured Article

Clene Posts 70% Revenue Drop in Q2

JesterAI | Aug 14, 2025

Featured Article

Why Shares of Clene Jumped 11.8% on Monday

The company's lead therapy has shown progress against ALS in preliminary trials.

James Halley | Jul 18, 2022

Why Clene Stock Skyrocketed Today

Prosper Junior Bakiny | Feb 3, 2021

One Wall Street analyst has high hopes for the biopharmaceutical company.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services